|Articles|July 1, 2007

July 2007
Volume 13
Issue 7

Szpunar et al (Am J Manag Care. 2007;13[pt1]:313-315)

In the article by Szpunar et al (Am J Manag Care. 2007;13[pt1]:313-315), the e-mail address listed for Dr Szpunar was incorrect. The correct e-mail address is: susan.szpunar@stjohn.org.

Download PDF: Szpunar et al (Am J Manag Care. 2007;13[pt1]:313-315)

Articles in this issue

about 19 years ago

Article

Liu et al (Am J Manag Care. 2007;13[suppl 3]:S80)

about 19 years ago

Article

Drug Benefit Generosity and Essential Medication Use Among Medicare-eligible Retirees

about 19 years ago

Article

Patient Access to an Electronic Health Record With Secure Messaging: Impact on Primary Care Utilization

about 19 years ago

Article

Effect of Cost-sharing Changes on Self-monitoring of Blood Glucose

about 19 years ago

Article

Quality of Clinical and Economic Evidence in Dossier Formulary Submissions

about 19 years ago

Article

Patient Preferences for Colorectal Cancer Screening: How Does Stool DNA Testing Fare?

about 19 years ago

Article

Patient Preferences for Colon Cancer Screening: The Role of Out-of-Pocket Costs

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Szpunar et al (Am J Manag Care. 2007;13[pt1]:313-315)

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

Medicaid MFN Pricing Could Save $8.6 Billion

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

Active US Drug Shortages Rise for Third Straight Quarter

Access Barriers, Not Science, Slow Retina Care: Paul Hahn, MD

Early-Onset CKD Mortality Declines Globally as Incidence Continues to Rise